U-Blot® Research Grade PamrevlumabCat. No. WA3328Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PamrevlumabCat. No. WA3328U-Blot® Research Grade pamlectabartCat. No. WA3327Request quote
Size: 50ug/100ug
U-Blot® Research Grade Palverafusp AlfaCat. No. WA3326Request quote
Size: 50ug/100ug
U-Blot® Research Grade PalivizumabCat. No. WA3325Request quote
Size: 50ug/100ug
U-Blot® Research Grade PagibaximabCat. No. WA3324Request quote
Size: 50ug/100ug
U-Blot® Research Grade PacmilimabCat. No. WA3323Request quote
Size: 50ug/100ug
U-Blot® Research Grade PacibekitugCat. No. WA3322Request quote
Size: 50ug/100ug
U-Blot® Research Grade PacanalotamabCat. No. WA3321Request quote
Size: 50ug/100ug
U-Blot® Research Grade Pabinafusp AlfaCat. No. WA3320Request quote
Size: 50ug/100ug
U-Blot® Research Grade OzuriftamabCat. No. WA3319Request quote
Size: 50ug/100ug
U-Blot® Research Grade OzureprubartCat. No. WA3318Request quote
Size: 50ug/100ug
U-Blot® Research Grade OzoralizumabCat. No. WA3317Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598